The CYPHER SELECT®Plus Sirolimus-eluting Coronary Stent has received CE marking within the European Union for treatment of patients with diabetes, a complex and often difficult-to-treat patient population.
Cardio
Edwards Lifesciences Receives CE Mark For New Transfemoral Transcatheter Valve Delivery System
Edwards Lifesciences Corporation announced today that it received CE Mark approval for European commercial sales of the new RetroFlex 3 transfemoral delivery system for the Edwards SAPIEN transcatheter heart valve.
FDA Grants Marketing Approval to NAVISTAR® THERMOCOOL® Catheter for Atrial Fibrillation
NAVISTAR® THERMOCOOL® Catheter first and Only Ablation Catheter Approved for Treatment of Heart Rhythm Disorder That Affects Up to 5 Million People in the U.S.
St. Jude Medical Announces U.S. Approval of Industry’s First Connector System Designed to Simplify Implant Process for Cardiac Resynchronization Therapy Devices
New lead and cardiac resynchronization system design is expected to offer implanting physicians a simpler and quicker procedure and reduces the volume of the leads and device in the chest pocket for heart failure patients
Flexible Stenting Solutions, Inc. Receives CE Mark for New FlexStent™ Femoropopliteal Self Expanding Stent System
Flexible Stenting Solutions, Inc., a leading developer of next-generation flexible stents, announced today it has received CE Mark for its FlexStent™ Femoropopliteal Self Expanding Stent System.
Isotechnika Announces Full Enrollment Achieved in Partner Atrium’s CONFIRM 1 Trial for Voclosporin Coated Coronary Stent System
Isotechnika Inc. announced today that its partner, Atrium Medical Corporation has completed patient enrollment for their CONFIRM 1, First-in-Man (FIM) drug coated coronary stent clinical trial evaluating Atrium’s CINATRATM voclosporin coated coronary stent system.
St. Jude Medical Announces Publication of 20-year Durability in Aortic and Mitral Stented Tissue Valves
Study reports excellent long-term durability of the St. Jude Medical Biocor™ Stented Tissue Valve for mitral and aortic valve replacement
Sorin Group Announces the Publication of Superior 21 Year Durability Data with the Mitroflow Valve in Peer-Reviewed Medical Journal
Sorin Group has announced the publication of 21-year durability data of its Mitroflow™ Aortic Pericardial Heart Valve
Live Total Knee Replacement Webcast
Live Total Knee Replacement Webcast Eases Patient Concerns
“Clingfilm” for surgeons
New Synthetic Surgical Sealant film bonds to form an air-tight, blood-tight and fluid-tight barrier
Imaging breakthroughs are ‘disrupting’ cardiac practice
Frank Rademakers, “Imaging: The Focus of Clinical Cardiology for Years to Come,” strikes a warning note.
Endoaortic Balloon Occlusion For Cardiac Surgery Guidance Issued
The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on endoaortic balloon occlusion for cardiac surgery.
Deaths Following Heart Surgery Could Be Reduced
The latest findings from the National Confidential Enquiry into Patient Outcome and Death (NCEPOD) show that over a fifth of patients do not get best care following Coronary Artery Surgery.
Edwards Lifesciences Receives FDA Approval For PERIMOUNT Magna Mitral Heart Valve
Edwards will launch the PERIMOUNT Magna mitral valve in the United States immediately.
Clinical trials, imaging lead busy agenda for cardiologists
Europe’s largest medical conference got under way at the Messe München over the weekend
Handheld ultrasound replacing stethoscopes in cardiology
Handheld echocardiography is becoming the stethoscope in doctors’ everyday work, according to Professor Juhani Knuuti of the PET Centre in Turku, Finland